An Observational Post-Authorisation Safety Study (PASS) of Patients with Chronic Opioid Use for Non-Cancer Pain and Cancer Pain who have Opioid-Induced Constipation (OIC) (Naldemedine PASS)

27/09/2021
23/04/2024
EU PAS number:
EUPAS43258
Study
Planned
Documents
Study protocol
Study results
Study report
Other information